Currently out of the existing stock ratings of Jennifer Kim, 42 are a BUY (95.45%), 2 are a HOLD (4.55%).

Jennifer Kim

Work Performance Price Targets & Ratings Chart

Analyst Jennifer Kim, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 20.56% that have a potential upside of 44.47% achieved within 161 days.

Jennifer Kim’s has documented 75 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSM, Insmed at 20-Jun-2024.

Wall Street Analyst Jennifer Kim

Analyst best performing recommendations are on GRAY (GRAYBUG VISION).
The best stock recommendation documented was for GRAY (GRAYBUG VISION) at 5/13/2021. The price target of $6 was fulfilled within 46 days with a profit of $2.39 (66.2%) receiving and performance score of 14.39.

Average potential price target upside

CKPT Checkpoint Therapeutics GRAY Graybug Vision INSM Insmed NOVN Novan AYTU Aytu BioScience PRQR ProQR Therapeutics BV ALLK Allakos PGEN Precigen EYPT Eyepoint Pharmaceuticals PSTX Poseida Therapeutics LPCN Lipocine OCGN Ocugen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$16.33 (444.96%)

$20

16 days ago
(04-Dec-2024)

0/10 (0%)

$15.92 (390.20%)

Buy

$8

$4.33 (117.98%)

$8

1 years 2 days ago
(18-Dec-2023)

1/3 (33.33%)

$6.17 (337.16%)

187

Buy

1 years 4 months 5 days ago
(15-Aug-2023)

0/2 (0%)

$8.34 (125.23%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jennifer Kim?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?